• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9551
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Heart Failure (2206)
Event Date 05/04/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
(b)(6) clinical study.It was reported that chest pain occurred.In (b)(6) 2018, the patient presented with myocardial infarction and was referred for cardiac catheterization and the index procedure was performed on the same day.The target lesion was located in the proximal left anterior descending artery (lad) with 100% stenosis and was 20 mm long, with a reference vessel diameter of 3.5 mm.The target lesion was treated with pre-dilatation and placement of a 24 x 3.50 mm promus premier drug-eluting stent.Following this intervention, post dilatation was performed with 0% residual stenosis.Four days post procedure, the patient presented with paroxysmal chest pain.The event was treated medically.The following day, the event was considered recovered/resolved.Seven days later, the patient was discharged on aspirin and other antiplatelet medication.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
Promus premier china registry clinical study.It was reported that chest pain occurred.In (b)(6) 2018, the patient presented with myocardial infarction and was referred for cardiac catheterization and the index procedure was performed on the same day.The target lesion was located in the proximal left anterior descending artery (lad) with 100% stenosis and was 20 mm long, with a reference vessel diameter of 3.5 mm.The target lesion was treated with pre-dilatation and placement of a 24 x 3.50mm promus premier drug-eluting stent.Following this intervention, post dilatation was performed with 0% residual stenosis.Four days post procedure, the patient presented with paroxysmal chest pain.The event was treated medically.The following day, the event was considered recovered/resolved.Seven days later, the patient was discharged on aspirin and other antiplatelet medication.It was further reported that in (b)(6) 2018, the patient was diagnosed with acute heart failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key7785746
MDR Text Key117190978
Report Number2134265-2018-60034
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/02/2019
Device Model Number9551
Device Catalogue Number9551
Device Lot Number0021373487
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/30/2018
Initial Date FDA Received08/15/2018
Supplement Dates Manufacturer Received10/01/2018
Supplement Dates FDA Received10/17/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-